Pilot study on the efficacy of golimumab in the induction and maintenance of clinical and endoscopic remission in patients with steroid-dependent ulcerative colitis.
Phase of Trial: Phase IV
Latest Information Update: 07 Apr 2017
At a glance
- Drugs Golimumab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 08 Apr 2015 New trial record